NCT07500259Recruiting
Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
The ColoPan study evaluates the scientific validity, reproducibility, and predictive performance of the Personalised Functional Profiling (PFP) platform in colorectal cancer and pancreatic ductal adenocarcinoma patients. It combines genomic sequencing with in vitro functional drug testing using patient-derived spheroids/organoids.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 188 (estimated)
- First submitted
- 24 Mar 2026
- Start date
- 11 Sept 2026
- Primary completion date
- 30 Sept 2029
- Lead sponsor
- Luxembourg Institute of Health
- Diseases
- Pancreatic cancer, Colorectal cancer
- NCT number
- NCT07500259
What you commit to
- Study type: Observational
- Planned participants: 188
- From 11 Sept 2026 to the primary completion date, 30 Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known active Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV) infection.
- Patients with any other life-threatening illness, significant organ dysfunction or any clinically relevant conditions that, according to the hospital physician, could compromise the patient's safety.
Other
- Female patient, pregnant, planning a pregnancy or breastfeeding.
- Patient unable to understand and provide informed consent and has no family member representing him/her.
Who the study is looking for
- Signed informed consent form
- ≥ 18 years of age
- Willing and able to comply with the protocol for the duration of the study, including data and sample collection
- Patient scheduled for surgery or biopsy (primary tumour or metastasis) PDAC
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpitaux Robert Schmuan Coordinator of this site? Confirm its status | Luxembourg | Luxembourg | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.